Severe Symptomatic Hyponatremia Caused by Low Dose Oral Cyclophosphamide: A Case Report / 대한신장학회지
Korean Journal of Nephrology
; : 647-650, 2011.
Article
在 En
| WPRIM
| ID: wpr-162488
Responsible library:
WPRO
ABSTRACT
Cyclophosphamide (CY), an alkylating agent, is frequently used in the treatment of various autoimmune disorders and malignancies. Acute hyponatremia is a well-known side effect of moderate to high dose intravenous CY treatment, but is rare in patients treated with low dose intravenous CY. We report the case of a severe symptomatic hyponatremia in a 68-year-old woman with renal impairment who was treated with oral CY (100 mg/day) for anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis (GN). This case demonstrates that even oral CY could be associated with life threatening acute hyponatremia and should be used with caution.
Key words
全文:
1
索引:
WPRIM
主要主题:
Antibodies, Antineutrophil Cytoplasmic
/
Cyclophosphamide
/
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
/
Glomerulonephritis
/
Hyponatremia
研究类型:
Diagnostic_studies
限制:
Aged
/
Female
/
Humans
语言:
En
期刊:
Korean Journal of Nephrology
年:
2011
类型:
Article